Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Breast Cancer Screening Discontinuation Guidelines

Age-Based Recommendations

  • The American College of Physicians recommends that breast cancer screening should be discontinued in average-risk women aged 75 years or older or in women with a life expectancy of 10 years or less, regardless of age 1, 2
  • Women should continue screening mammography as long as their overall health is good and they have a life expectancy of 10 years or more, as recommended by the American Cancer Society 3, 4
  • For women aged 75 years and older, the decision to discontinue screening should incorporate risk for cancer death, competing risks for other causes of death, and individual patient's values and preferences, according to the American College of Physicians 1, 2

Life Expectancy Considerations

  • Among 70-year-old women with no comorbid conditions, average life expectancy is approximately 19 years, and among 75-year-old women with no comorbid conditions, average life expectancy is approximately 15 years, as reported by the American College of Physicians 2
  • Average life expectancy is approximately 11 years for 70-year-old women with serious comorbid conditions, and approximately 9 years for 75-year-old women with serious comorbid conditions, according to the American College of Physicians 2

Comorbidity Assessment

  • The American College of Physicians recommends that screening should be discontinued in women with significant comorbidities that limit life expectancy, such as chronic obstructive pulmonary disease, heart failure, end-stage liver disease, end-stage renal failure, and dementia 1, 2

Balancing Benefits and Harms

  • Older women face a higher probability of developing and dying from breast cancer but also have a greater chance of dying from other causes, as noted by the American College of Physicians 6
  • Potential harms of continued screening in older women include false-positive results leading to unnecessary anxiety, additional imaging studies, unnecessary biopsies, overdiagnosis of indolent disease, and overtreatment, according to the American College of Physicians 1, 7

Decision-Making Framework

  • The American College of Physicians recommends a decision-making framework that assesses the woman's overall health status and comorbidities, estimates life expectancy, and discontinues screening if life expectancy is less than 10 years 1, 2
  • If life expectancy is greater than 10 years, the American College of Physicians recommends continuing screening with biennial mammography 2

Common Pitfalls to Avoid

  • The American College of Physicians advises against using age alone as the sole criterion to discontinue screening without considering overall health status, and against continuing screening in women with significant comorbidities who are unlikely to benefit due to limited life expectancy 1, 7
  • Failing to engage in shared decision-making about the benefits and harms of continued screening in older women is also a common pitfall to avoid, as noted by the American College of Physicians 6